Company Filing History:
Years Active: 1996-1998
Title: Innovator Spotlight: Masayuki Ishihara
Introduction
Masayuki Ishihara, a notable inventor based in Alameda, California, has made significant contributions to the field of biotechnology. With a focus on therapeutic methods and glycosaminoglycan research, he holds two patents that open new avenues for medical treatments.
Latest Patents
Ishihara's latest patents include innovative approaches that utilize O-desulfated heparin derivatives. His first patent outlines therapeutic methods incorporating these compositions—particularly 6-O-desulfated heparin compositions—which are useful in treating a variety of diseases, including cancer, angiogenesis, shock, ischemia reperfusion injury, inflammation, and cardiovascular diseases like restenosis. His second patent focuses on glycosaminoglycan specific sulfotransferases, detailing the DNA encoding a polypeptide capable of catalyzing the deacetylation and sulfation of glycosaminoglycans. These patents also cover the production and isolation of recombinant and synthetic polypeptides, along with their therapeutic applications.
Career Highlights
Throughout his career, Ishihara has worked in prominent roles within notable organizations such as Glycomed, Inc. and the University of Massachusetts. His work has significantly impacted the development of therapies and innovations in biotechnology.
Collaborations
Ishihara has collaborated with esteemed colleagues, including Kevin R. Holme and Patrick N. Shaklee, contributing to collective advancements in their respective fields. These partnerships have played a vital role in enhancing the scope and effectiveness of their research.
Conclusion
Masayuki Ishihara's innovative spirit and dedication to advancing medical science through his patents exemplify the importance of research in addressing complex health challenges. His work continues to inspire future innovations that may lead to groundbreaking treatments for various diseases.